Correction: Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65

類似資料

• Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65
  著者:: Georgiadis, A, 等
  出版事項: (2016)
• Severe Loss of Tritan Color Discrimination in RPE65 Associated Leber Congenital Amaurosis
  著者:: Kumaran, Neruban, 等
  出版事項: (2018)
• A Cross-Sectional and Longitudinal Study of Retinal Sensitivity in RPE65-Associated Leber Congenital Amaurosis
  著者:: Kumaran, Neruban, 等
  出版事項: (2018)
• Safety and Long-Term Efficacy of AAV4 Gene Therapy in Patients with RPE65 Leber Congenital Amaurosis
  著者:: Le Meur, Guylène, 等
  出版事項: (2018)
• Rpe65(−/−) and Lrat(−/−) Mice: Comparable Models of Leber Congenital Amaurosis
  著者:: Fan, Jie, 等
  出版事項: (2008)